| Advice You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How to Write a Letter to the Editor that Gets Published and Read |
|
Advice You - How to Write a Letter to the Editor that Gets Published and Read
We've all read bang-up letters to the editor focused on a recent event or issue covered by a publication or TV or radio coverage. More recently, I've seen letters crafted in response to websites and e-newslett According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ers. It's much more likely that your organization's letter will run than it is to place an op-ed piece or get your nonprofit covered in a feature article. Unlike news stories, letters to the editor enable you ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in r nonprofit or foundation to state an opinion, offer an alternative viewpoint, heap praise, or move someone to action, in your own words. That means there's a much smaller chance that the facts will be wrong o lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. r that your message will be twisted or diluted as it might be in a news or feature story written by a reporter. The benefits for your nonprofit include:
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe i>Raising its profile. But writing an opinion letter that gets published and has the desired impact is both an art and a science. Here are 10 practical tips d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro for writing a letter to the editor that gets published and read:
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc t efforts on. Don't forget trade publications, and community and weekly newspapers. Depending on your audience, those venues can have greater influence than an opinion letter in the NYT. And it's easier to get easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi letters to the editor published in these smaller publications. Once you have your target list, you're ready to respond when an opportunity surfaces.
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically on for your target listMost publications and programs publicize what they want in a letter to the editor, and how and to whom to send it. Examples include: Asheville (NC) Citizen Times – c and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ onditions for rejection http://orig.citizen-times.com/service/faq/letters_policy.shtml Chronicle of Philanthropy – via snail or email http://philanthropy.com/about/letters.htm The New York Times – maximum of ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi 150 http://www.nytimes.com/top/opinion/editorialsandoped/letters/ The Washington Post – letters must be exclusive to the Post http://www.washingtonpost.com/wpsrv/edit/letters/letterform.htm
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a eference a recent print or broadcast articleWrite your organization's letter as a direct response to recent coverage, building on the focus presented or emphasizing how your organization's p dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod erspective wasn't presented (and presenting it clearly).
cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin a letter or at least key message points so your nonprofit is prepared to finalize and submit your letter pronto.
tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen /strong>Read letters in your target venues on a regular basis to learn how to write the most effective letter.
t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ation will shorten your letter to fit its format. The more it has to edit, the less control you have of what gets printed.
Include two to three paragraphs, each with no more than three sentences.
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Freight Factoring: A Financing Solution for the Trucking Industry Does the Brand Equity Influence the Customers' Loyalty?
|